Press Releases Mauna Kea Technologies

Equities

ALMKT

FR0010609263

Market Closed - Euronext Paris Other stock markets 11:35:18 2024-04-26 am EDT			5-day change	1st Jan Change
0.39 ^EUR	+2.77%		0.00%	-17.20%

Apr. 25	Mauna Kea Technologies SA Provides Sales Guidance for the Year 2024	CI
Apr. 03	Mauna Kea: first Italian center for Cellvizio	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mauna Kea Technologies : Inside Information / Information on annual revenues	Apr. 25	PU
Mauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales	Apr. 25	BU
Mauna Kea Technologies : Reports Full Year 2023 Results and Q1 2024 Sales	Apr. 25	PU
Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank	Apr. 24	BU
Mauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	Apr. 02	BU
Mauna Kea Technologies : Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	Apr. 02	PU
Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio	Mar. 27	BU
Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	Mar. 06	BU
MAUNA KEA TECHNOLOGIES REPORTS FULL YEAR 2023 SALES OF EUR10.5M, UP +42% VS 2022	Jan. 26	AQ
Mauna Kea Technologies : Inside Information / Other news releases	Nov. 02	PU
Mauna Kea Technologies Announces the Publication of Positive Results of a Randomized Controlled Trial in the Field of Interstitial Lung Disease	23-10-18	AQ
Mauna Kea Technologies secures an equity line financing with Vester Finance limited to a maximum of 11.4% of the capital	23-06-01	AQ
Mauna Kea Technologies Announces Sales of EUR4.2 million for the first quarter of 2023, up 121% from 2022	23-04-21	AQ
Mauna Kea Technologies Announces the Publication of Results of the First in Human Clinical Study Combining Robotic-Assisted Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy for Lung Cancer	23-01-13	AQ
Mauna Kea Technologies reports its Financial Results for the First Half of 2022	22-11-17	AQ
Mauna Kea Technologies Announces Success of Clinical Trial on Prediction of Remission in Patients with Inflammatory Bowel Disease and its Publication in Gastroenterology	22-11-01	AQ
Mauna Kea Technologies : Announces 2022 Nine Month Sales Results	22-10-27	PU
Mauna Kea Technologies : Announces Q2 and 1H 2022 Revenues	22-07-21	PU
Mauna Kea Technologies : Announces Start of Enrollment in Peripheral Lung Cancer Multi-Center Clinical Trial	22-02-22	PU
Mauna Kea Technologies : Announces 5 Communications Highlighting the Clinical Value of Cellvizio® in Interventional Pulmonology Presented During the ERS International Congress 2021	21-10-04	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mauna Kea Technologies

Equities

ALMKT

FR0010609263

Press Releases

Filters